Showing results (41-50 of 332) with videos related to

Sort By:
Pageof 34
Current Opinion in Immunology|October 1, 1996
Peptide-based cancer vaccinesC J Melief, R Offringa, R E Toes, et al.
European Cytokine Network|February 12, 1998
Inflammatory properties of peptidoglycan are decreased after degradation by human N-acetylmuramyl-L-alanine amidaseM A Hoijer, M J Melief, R Debets, et al.
Pigment Cell & Melanoma Research|June 22, 2011
Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunityJasper G van den Boorn, Cornelis J Melief, Rosalie M Luiten
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2W M Kast, R M Brandt, J W Drijfhout, et al.
Current Pharmaceutical Design|May 18, 2012
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigenRenee Vermeij, Ninke Leffers, Cornelis J Melief, et al.
European Journal of Immunology|September 1, 1989
Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytesL Rozendaal, S T Pals, M Schilham, et al.
International Journal of Cancer|June 15, 1989
Retrovirally induced murine B-cell tumors rarely show proviral integration in sites common in T-cell tumorsE A Matthews, W L Vasmel, H J Schoenmakers, et al.
Pageof 34